Analyze Diet

Topic:Antibodies

Antibodies in horses are specialized proteins produced by the immune system in response to foreign substances, known as antigens. These substances can include pathogens such as bacteria, viruses, and parasites. Antibodies function by recognizing and binding to specific antigens, thereby neutralizing them or marking them for destruction by other immune cells. In equine health, antibodies are integral to both natural immune responses and those induced by vaccinations. The study of antibodies in horses encompasses their production, diversity, and role in disease resistance and management. This page gathers peer-reviewed research studies and scholarly articles that explore the generation, function, and implications of antibodies in equine immunology and disease control.
Equine herpesviruses 1 and 4: creeping to a solution.
Veterinary journal (London, England : 1997)    May 26, 2005   Volume 170, Issue 1 6-7 doi: 10.1016/j.tvjl.2004.07.001
Smith K.No abstract available
Effect of vaccination against leptospirosis on the frequency, days to recurrence and progression of disease in horses with equine recurrent uveitis.
Veterinary ophthalmology    May 25, 2005   Volume 8, Issue 3 171-179 doi: 10.1111/j.1463-5224.2005.00367.x
Rohrbach BW, Ward DA, Hendrix DV, Cawrse-Foss M, Moyers TD.To evaluate the effect of vaccination against leptospirosis on frequency and days to recurrence of uveitis and progression of disease in horses with equine recurrent uveitis (ERU). Methods: Forty-one horses with ERU. Methods: Horses were randomly assigned to experimental (vaccinated) or control groups. Vaccine containing six serovars of Leptospira or placebo was administered, an ophthalmic examination performed and blood samples drawn on days 0, 28, 180 and 365. Antibody titers were measured against each serovar. Recurrence of uveitis was verified by ophthalmic examination. Results of the init...
Prevalence and diagnosis of parasites of the stomach and small intestine in horses in south-west England.
The Veterinary record    May 10, 2005   Volume 156, Issue 19 597-600 doi: 10.1136/vr.156.19.597
Morgan ER, Hetzel N, Povah C, Coles GC.Parasites were extracted from the stomach and small intestine of 118 horses at slaughter. The most abundant species was the tapeworm Anoplocephala perfoliata. Maximum likelihood analysis was used to investigate the relationship between the number of worms and their total weight, and the ability of an antibody-based elisa to diagnose the level of infection. The total weight of tapeworms increased towards a maximum as the number of worms increased, suggesting a population density-dependent constraint on the weight. The number of A perfoliata present could be predicted approximately from the resu...
Antibiotic treatment of experimentally Borrelia burgdorferi-infected ponies.
Veterinary microbiology    May 3, 2005   Volume 107, Issue 3-4 285-294 doi: 10.1016/j.vetmic.2005.02.006
Chang YF, Ku YW, Chang CF, Chang CD, McDonough SP, Divers T, Pough M, Torres A.The objective of this study is to determine whether doxycycline, ceftiofur or tetracycline could be effectively used to treat equine Lyme disease. Ponies experimentally infected with Borrelia burgdorferi by tick exposure were treated with doxycycline, ceftiofur or tetracycline for 4 weeks (28 days). Doxycyline and ceftiofur treatment were inconsistent in eliminating persistent infection in this experimental model. However, tetracycline treatment seems to eliminate persistent infection. Although serum antibody levels to B. burgdorferi in all ponies declined gradually after antibiotic treatment,...
Ulcerative dermatitis, thrombocytopenia, and neutropenia in neonatal foals.
Journal of veterinary internal medicine    April 13, 2005   Volume 19, Issue 2 211-216 doi: 10.1892/0891-6640(2005)192.0.co;2
Perkins GA, Miller WH, Divers TJ, Clark CK, Belgrave RL, Sellon DC.This report describes transient ulcerative dermatitis, severe thrombocytopenia, and mild neutropenia in 6 foals from 4 mares from geographically diverse regions of the United States. The foals presented at <4 days of age with oral and lingual ulcers, and crusting and erythema around the eyes, muzzle, and perineal, inguinal, axillary, trunk, and neck regions. There was a severe thrombocytopenia (0-30,000 platelets/microL), leukopenia (1900-3200 white blood cells/microL), and mild neutropenia (500-1800 neutrophils/microL). Four of the 6 foals had petechiae and ecchymotic hemorrhages and 3 had bl...
Acute clinical, hematologic, serologic, and polymerase chain reaction findings in horses experimentally infected with a European strain of Anaplasma phagocytophilum.
Journal of veterinary internal medicine    April 13, 2005   Volume 19, Issue 2 232-239 doi: 10.1892/0891-6640(2005)192.0.co;2
Franzén P, Aspan A, Egenvall A, Gunnarsson A, Aberg L, Pringle J.Six horses were experimentally infected by administration of horse blood containing a Swedish strain of Anaplasma phagocytophilum. The polymerase chain reaction (PCR) signal was consistently detected 2-3 days before appearance of clinical signs and persisted 4-9 days beyond abatement of clinical signs, whereas diagnostic inclusion bodies were 1st noted on average 2.6 +/- 1.5 (SD) days after onset of fever. Clinical signs and hematologic changes were largely indistinguishable from those previously reported for diseases caused by A phagocytophilum (formerly Ehrlichia equi--"Californian agent") a...
A recombinant envelope protein vaccine against West Nile virus.
Vaccine    April 6, 2005   Volume 23, Issue 30 3915-3924 doi: 10.1016/j.vaccine.2005.03.006
Ledizet M, Kar K, Foellmer HG, Wang T, Bushmich SL, Anderson JF, Fikrig E, Koski RA.West Nile (WN) virus is a flavivirus that first appeared in North America in 1999. Since then, more than 600 human deaths and 22,000 equine infections have been attributed to the virus in the United States. We expressed a truncated form of WN virus envelope (E) protein in Drosophila S2 cells. This soluble recombinant E protein was recognized by antibodies from naturally infected horses, indicating that it contains native epitopes. Mice and horses produced high-titer antibodies when immunized with recombinant E protein combined with aluminum hydroxide. Immunized mice were resistant to challenge...
Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Veterinary immunology and immunopathology    March 31, 2005   Volume 105, Issue 1-2 47-57 doi: 10.1016/j.vetimm.2004.12.012
Foote CE, Love DN, Gilkerson JR, Rota J, Trevor-Jones P, Ruitenberg KM, Wellington JE, Whalley JM.The envelope glycoprotein D of equine herpesvirus 1 (EHV-1 gD) has been shown in laboratory animal models to elicit protective immune responses against EHV-1 challenge, and hence is a potential vaccine antigen. Here we report that intramuscular inoculation of EHV-1 gD produced by a recombinant baculovirus and formulated with the adjuvant Iscomatrix elicited virus-neutralizing antibody and gD-specific ELISA antibody in the serum of over 90% of adult mixed breed horses. The virus-neutralizing antibody responses to EHV-1 gD were similar to those observed after inoculation with a commercially avai...
Horse cytokine/IgG fusion proteins–mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
Veterinary immunology and immunopathology    March 31, 2005   Volume 105, Issue 1-2 1-14 doi: 10.1016/j.vetimm.2004.11.010
Wagner B, Robeson J, McCracken M, Wattrang E, Antczak DF.Recombinant cytokines are valuable tools for functional studies and candidates for vaccine additives or therapeutic use in various diseases. They can also be used to generate specific antibodies to analyze the roles of different cytokines during immune responses. We generated a mammalian expression system for recombinant cytokines using the equine IgG1 heavy chain constant region as a tag for detection and purification of the expressed cytokine, demonstrated here using equine interferon-gamma (IFN-gamma), interleukin-2 (IL-2), interleukin-4 (IL4) and transforming growth factor-beta1 (TGF-beta1...
Prevalence of neutralizing antibodies to Equine rhinitis A and B virus in horses and man.
Veterinary microbiology    March 22, 2005   Volume 106, Issue 3-4 293-296 doi: 10.1016/j.vetmic.2004.12.029
Kriegshäuser G, Deutz A, Kuechler E, Skern T, Lussy H, Nowotny N.Equine rhinitis viruses (ERVs) are the causative agents of mild to severe upper respiratory infections in horses worldwide. Immunologically, four serotypes of ERVs have been identified. Equine rhinitis A virus (ERAV) and Equine rhinitis B virus 1 (ERBV1) are the most frequent serotypes in Europe. Both viruses have a broad host range in cultured cells with ERAV being able to infect humans. Since there is neither information on the seroprevalence of ERAV and ERBV1 in Austria nor on the zoonotic potential of ERBV1, we investigated 200 horse and 137 veterinary sera for the presence of neutralizing...
In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.
Gene therapy    March 18, 2005   Volume 12, Issue 12 988-998 doi: 10.1038/sj.gt.3302484
Lamikanra A, Myers KA, Ferris N, Mitrophanous KA, Carroll MW.Lentiviral-based vectors hold great promise as gene delivery vehicles for the treatment of a wide variety of diseases. We have previously reported the development of a nonprimate lentiviral vector system based on the equine infectious anaemia virus (EIAV), which is able to efficiently transduce dividing and nondividing cells both in vitro and in vivo. Here, we report on the application of EIAV vectors for the systemic delivery of an antibody fusion protein designed for the treatment of cancer. The therapeutic potential of a single chain antibody against the tumour-associated antigen, 5T4, fuse...
Equine viral arteritis control scheme: a brief review with emphasis on laboratory aspects of the scheme in New Zealand.
New Zealand veterinary journal    March 16, 2005   Volume 52, Issue 2 82-84 doi: 10.1080/00480169.2004.36409
Horner GW.To review laboratory aspects of the equine viral arteritis (EVA) control scheme in New Zealand between 1989 and 2002. Methods: The optimisation and performance of the virus neutralisation test (VNT) for equine arteritis virus (EAV) antibody, and the cell culture test to detect EAV in semen were analysed. Laboratory data and control scheme results were reviewed. Results: Using optimised tests, it has been shown that antibody prevalence in Standardbred horses has steadily declined from 54% to <20%. Prevalences in Thoroughbred horses have remained at a low level of around 3%. The number of horses...
Effects of GnRH immunization in sexually mature pony stallions.
Animal reproduction science    March 16, 2005   Volume 86, Issue 3-4 247-259 doi: 10.1016/j.anireprosci.2004.07.010
Turkstra JA, van der Meer FJ, Knaap J, Rottier PJ, Teerds KJ, Colenbrander B, Meloen RH.Immunization against gonadotrophin releasing hormone (GnRH) was studied as an alternative for the commonly used surgical castration in stallions. Two GnRH vaccines comprising non-mineral oil adjuvants were evaluated for their potential to induce high antibody titers directed against GnRH and subsequent effects on reproductive characteristics. Twelve sexually mature male hemicastrated Shetland ponies were assigned to three groups. Group 1 and 2 were injected with 1mg peptide equivalent of G6k-GnRH-tandem-dimer conjugated to ovalbumin (OVA) in CoVaccine HT adjuvant (GnRH/CoVaccine) and in Carbop...
Efficacy of DNA vaccination against western equine encephalitis virus infection.
Vaccine    March 10, 2005   Volume 23, Issue 17-18 2280-2283 doi: 10.1016/j.vaccine.2005.01.032
Nagata LP, Hu WG, Masri SA, Rayner GA, Schmaltz FL, Das D, Wu J, Long MC, Chan C, Proll D, Jager S, Jebailey L, Suresh MR, Wong JP.The efficacy of a DNA vaccine against western equine encephalitis (WEE) infection in mice was evaluated. The 26S structural region was expressed, in vitro from an internal T7 promoter using a rabbit reticulysate transcription/translation system; and from a CMV promoter after transfection into Vero cell monolayers. The proteins synthesized were reactive with anti-WEE virus (WEEV) antibodies, both in western blot analysis and histochemical staining, respectively. When the DNA vaccine plasmid, pVHX-6, was administered intraepidermally to mice, followed by challenge in a lethal mouse model, the le...
The improvement of the therapeutic anti-Lachesis muta serum production in horses.
Toxicon : official journal of the International Society on Toxinology    March 1, 2005   Volume 45, Issue 4 467-473 doi: 10.1016/j.toxicon.2004.12.006
Stephano MA, Guidolin R, Higashi HG, Tambourgi DV, Sant'Anna OA.The main features associated with pit viper envenomations include the intense local lesions such as oedema, necrosis, acute renal failure and other effects. The severity of these reactions to snakebite depends on the degree of envenomation. Lachesis muta venom (LMV) has weak lethal activity, but due to the large amount often inoculated, the effects are extremely severe and demand anti-venom with a high neutralizing capacity. LMV had the lowest neutralizing antibody induction capacity in horses when compared with that of other venoms. For example, Bothrops anti-venom serum neutralizes 180 times...
Assessment in mice of vapA-DNA vaccination against Rhodococcus equi infection.
Veterinary immunology and immunopathology    March 1, 2005   Volume 104, Issue 3-4 215-225 doi: 10.1016/j.vetimm.2004.12.006
Haghighi HR, Prescott JF.There is a need to produce a vaccine against Rhodococcus equi pneumonia in foals in which immunity against infection is largely based on a type 1, cell-mediated, immune response. The VapA protein of the virulence plasmid of R. equi is highly immunogenic. To assess the potential of vapA-DNA to produce immunity, C57BL/6 and BALB/c mice were immunized with a DNA vaccine constructed from vapA incorporated into pcDNA3.1. The plasmid construct expressed VapA in a COS-7 cell line. Intramuscular immunization of mice resulted in enhanced clearance of R. equi from the liver of intravenously challenged m...
Pregnancy status determination in mares using a rapid lateral flow test for measuring serum oestrone sulphate.
New Zealand veterinary journal    February 24, 2005   Volume 52, Issue 4 193-196 doi: 10.1080/00480169.2004.36428
Henderson KM, Eayrs K.To develop a means of determining pregnancy status in horses based on measuring serum oestrone sulphate (OS) concentrations using a rapid lateral flow immunoassay, and to determine the assay's effectiveness using a visual end-point. Methods: Serum samples from mares >100 days post-mating (n=701) were assayed using a nitrocellulose membrane-based lateral flow immunoassay device. The device was developed using membrane-bound 1,3,5 (10)-estratrien-3-ol-17-one conjugated to bovine serum albumin as the capture antigen, and an OS-detection monoclonal antibody coupled to colloidal gold as the visi...
The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine.
Veterinary therapeutics : research in applied veterinary medicine    February 19, 2005   Volume 5, Issue 4 251-257 
Grosenbaugh DA, Backus CS, Karaca K, Minke JM, Nordgren RM.A new recombinant West Nile virus (WNV) vaccine has been licensed for use in horses. Prior to the availability of the recombinant vaccine in 2004, the only equine WNV vaccine available on the market had been an inactivated vaccine. Since the recombinant vaccine only expresses selected viral genes, the question could be posed as to whether a single dose of the recombinant vaccine would be effective in producing an anamnestic serologic response in horses previously vaccinated with an inactivated WNV vaccine. In this study we demonstrate that vaccination of horses with a canarypox-vectored recomb...
Risk of transplacental transmission of Sarcocystis neurona and Neospora hughesi in California horses.
The Journal of parasitology    February 18, 2005   Volume 90, Issue 6 1345-1351 doi: 10.1645/GE-3372
Duarte PC, Conrad PA, Barr BC, Wilson WD, Ferraro GL, Packham AE, Carpenter TE, Gardner IA.The study objective was to assess the risk of transplacental transmission of Sarcocystis neurona and Neospora hughesi in foals from 4 California farms during 3 foaling seasons. Serum of presuckle foals and serum and colostrum of periparturient mares were tested using indirect fluorescent antibody tests for S. neurona and N. hughesi. Serum antibody titers were < or =10 in 366 presuckle foals tested. There was no serologic or histologic evidence of either parasite in aborted fetuses or placentas examined. Positivity for S. neurona and N. hughesi in mares increased with age. Mares < or =9 y...
Experimental infection of ponies with Sarcocystis fayeri and differentiation from Sarcocystis neurona infections in horses.
The Journal of parasitology    February 18, 2005   Volume 90, Issue 6 1487-1491 doi: 10.1645/GE-313
Saville WJ, Dubey JP, Oglesbee MJ, Sofaly CD, Marsh AE, Elitsur E, Vianna MC, Lindsay DS, Reed SM.Sarcocystis neurona and Sarcocystis fayeri infections are common in horses in the Americas. Their antemortem diagnosis is important because the former causes a neurological disorder in horses, whereas the latter is considered nonpathogenic. There is a concern that equine antibodies to S. fayeri might react with S. neurona antigens in diagnostic tests. In this study, 4 ponies without demonstrable serum antibodies to S. neurona by Western immunoblot were used. Three ponies were fed 1 x 10(5) to 1 x 10(7) sporocysts of S. fayeri obtained from dogs that were fed naturally infected horse muscles. A...
Immunologic responses to West Nile virus in vaccinated and clinically affected horses.
Journal of the American Veterinary Medical Association    February 15, 2005   Volume 226, Issue 2 240-245 doi: 10.2460/javma.2005.226.240
Davidson AH, Traub-Dargatz JL, Rodeheaver RM, Ostlund EN, Pedersen DD, Moorhead RG, Stricklin JB, Dewell RD, Roach SD, Long RE, Albers SJ, Callan RJ....To compare neutralizing antibody response between horses vaccinated against West Nile virus (WNV) and horses that survived naturally occurring infection. Methods: Cross-sectional observational study. Methods: 187 horses vaccinated with a killed WNV vaccine and 37 horses with confirmed clinical WNV infection. Methods: Serum was collected from vaccinated horses prior to and 4 to 6 weeks after completion of an initial vaccination series (2 doses) and 5 to 7 months later. Serum was collected from affected horses 4 to 6 weeks after laboratory diagnosis of infection and 5 to 7 months after the first...
Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy.
Journal of virology    February 15, 2005   Volume 79, Issue 5 2666-2677 doi: 10.1128/JVI.79.5.2666-2677.2005
Craigo JK, Li F, Steckbeck JD, Durkin S, Howe L, Cook SJ, Issel C, Montelaro RC.Among the diverse experimental vaccines evaluated in various animal lentivirus models, live attenuated vaccines have proven to be the most effective, thus providing an important model for examining critical immune correlates of protective vaccine immunity. We previously reported that an experimental live attenuated vaccine for equine infectious anemia virus (EIAV), based on mutation of the viral S2 accessory gene, elicited protection from detectable infection by virulent virus challenge (F. Li et al., J. Virol. 77:7244-7253, 2003). To better understand the critical components of EIAV vaccine e...
Detection of antibodies to Borrelia burgdorferi in naturally infected horses in the USA by enzyme-linked immunosorbent assay using whole-cell and recombinant antigens.
Research in veterinary science    February 9, 2005   Volume 79, Issue 2 99-103 doi: 10.1016/j.rvsc.2004.11.009
Magnarelli L, Fikrig E.Blood samples were collected from 98 horses suspected of having borreliosis or granulocytic ehrlichiosis in Connecticut and New York State, USA during 1985, 1995, and 1996. Serum antibodies to Borrelia burgdorferi were detected by an enzyme-linked immunosorbent assay (ELISA), based on whole-cell and recombinant antigens, in 82 (84%) horses. Of the 181 sera tested, 59% were positive, using whole-cell antigens, compared to 48% with protein (p)37 and 35% with VlsE antigens. An ELISA containing either of these fusion proteins can be used as an adjunct to general screening by an ELISA or immunoblot...
Measurement of erythrocyte carbonic anhydrase isozymes (CA-I and CA-II) in racehorses and riding horses.
The Journal of veterinary medical science    February 9, 2005   Volume 67, Issue 1 63-67 doi: 10.1292/jvms.67.63
Nishita T, Takahasi M, Kasuya T, Matsui K, Ichihara N, Murakami M, Asari M.Equine carbonic anhydrase isozymes (CA-I and CA-II) were purified from erythrocytes by several column chromatography. Polyclonal anti-CA-I and anti-CA-II sera were produced in rabbits. Sensitive competitive enzyme-linked immunosorbent assays (ELISA) were established to determine the developmental changes in CA-I and CA-II levels in equine erythrocytes. Concentrations of CA-I and CA-II in erythrocytes from 150 clinically normal thoroughbreds (123 racehorses and 27 riding horses) were determined by ELISA. Mean (+/- SD) concentrations of CA-I and CA-II in racehorses were 1.70 +/- 0.48 and 0.94 +/...
Persistence of anti-zonae pellucidae antibodies following a single inoculation of porcine zonae pellucidae in the domestic equine.
Reproduction (Cambridge, England)    February 8, 2005   Volume 129, Issue 2 181-190 doi: 10.1530/rep.1.00168
Liu IK, Turner JW, Van Leeuwen EM, Flanagan DR, Hedrick JL, Murata K, Lane VM, Morales-Levy MP.In this study of equids, we investigated the antibody response and the effect on the estrous cycle following a single inoculation of porcine zonae pellucidae (pZP) employing controlled-release methodology. We also investigated the use of two different water-soluble adjuvants as an alternative to oil-based adjuvants. Twenty-seven domestic mares were inoculated with various formulations of pZP and adjuvant. We showed that the anti-pZP antibodies generated as a result of the inoculations persisted for at least 43 weeks (length of the study). Of the various formulations used in the study, pZP and ...
Diagnostic application of immunoperoxidase monolayer assay using monoclonal antibodies produced against equine arteritis virus 14-kDa nucleocapsid protein.
Hybridoma and hybridomics    February 3, 2005   Volume 23, Issue 6 368-372 doi: 10.1089/hyb.2004.23.368
Hornyák A, Dénes B, Szeredi L, Dencsö L, Rusvai M.Two monoclonal antibodies against the Bucyrus strain of equine arteritis virus (EAV) were produced, and according to immunoperoxidase reaction following Western blot of electrophoresed EAV structural proteins, they recognized the nucleocapsid (N) protein antigen (14-kDa protein). Besides reacting with the blotted polypeptide, the antibodies of the two clones (designated 1H1 and 4G6) selected from 576 have shown high affinity and specificity to intracellular virus antigen as well. Both antibodies reacted with the representatives of the different subtypes of equine arteritis virus providing a su...
Characterisation and quantification of equine interferon gamma.
Veterinary immunology and immunopathology    January 22, 2005   Volume 104, Issue 1-2 105-115 doi: 10.1016/j.vetimm.2004.11.004
Gutmann S, Zawatzky R, Müller M.Interferon-gamma (IFN-gamma) is a key cytokine in cell-mediated immunity. To measure IFN-gamma production of equine lymphocytes (eqIFN-gamma), we developed a quantitative ELISA. Monoclonal antibodies (mAb) were produced against bacterially derived eqIFN-gamma. The mAbs recognised recombinant and lymphocyte-derived eqIFN-gamma in ELISA, Western blotting, as well as flow cytometric and microscopic analysis. In contrast to bacterially derived material, mammalian and insect cell-derived eqIFN-gamma was biologically active but could be neutralised by one of the monoclonal antibodies. Unexpectedly, ...
Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
Journal of virological methods    January 18, 2005   Volume 125, Issue 1 55-65 doi: 10.1016/j.jviromet.2004.12.002
Maree S, Paweska JT.This paper describes the production and purification of a group-specific recombinant protein VP7 of African horse sickness virus serotype 3 (AHSV-3) and validation of an I-ELISA for the detection of IgG-antibodies to VP7 in horse sera. Baculovirus-expressed VP7 crystals were purified from infected insect cells. Analytical accuracy of the I-ELISA was examined using sera (n = 38) from an experimentally infected horse, from foals born to vaccinated mares, from guinea-pigs immunized with nine serotypes of AHSV, and from sera of animals infected with other orbiviruses. Compared to traditional serol...
Lawsonia intracellularis proliferative enteropathy in a weanling foal in Australia.
Australian veterinary journal    January 15, 2005   Volume 82, Issue 12 750-752 doi: 10.1111/j.1751-0813.2004.tb13236.x
McClintock SA, Collins AM.A 6-month-old Quarter Horse weanling filly was presented with lethargy, weight loss, inappetance, mild diarrhoea, marked ventral oedema and severe panhypoproteinaemia. Serum antibody titres for Lawsonia intracellularis were very high but PCR to detect faecal shedding of the organism was negative. Proliferative enteropathy due to L. intracellularis infection was diagnosed. After treatment for 4 weeks with oral erythromycin and rifampicin the filly made a complete recovery.
Identification of another B-cell epitope in the type-specific region of equine herpesvirus 4 glycoprotein G.
Clinical and diagnostic laboratory immunology    January 12, 2005   Volume 12, Issue 1 122-124 doi: 10.1128/CDLI.12.1.122-124.2005
Maeda K, Mizukoshi F, Hamano M, Kai K, Kondo T, Matsumura T.Recently, a novel 12-mer B-cell epitope, MKNNPIYSEGSL, in the type-specific region of equine herpesvirus 1 (EHV-1) glycoprotein G (gG) was identified and used as an antigen for enzyme-linked immunosorbent assay (Maeda et al., J. Clin. Microbiol. 42:1095-1098, 2004). Although our prototype strain, TH20p, possesses two repeat sequences containing the B-cell epitope, the EHV-4 NS80567 strain has two repeat sequences that are not identical. One repeat sequence stretch contained the B-cell epitope, while the other contained the 11-mer, MKNNPVYSESL (underlining indicates a different amino acid). In ...
1 48 49 50 51 52 109